Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Science Translational Medicine, 2021Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
D’Agnillo F., Walters K., Xiao Y. et al.
Olink Target 96
Immunity, 2021APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis
Wu J., Ma Z., Raman A. et al.
Journal of the American College of Cardiology, 2021Proteomics-Enabled Deep Learning Machine Algorithms Can Enhance Prediction of Mortality
Unterhuber M., Kresoja K., Rommel K. et al.
Genes, 2021Multiplex Protein Biomarker Profiling in Patients with Familial Hypercholesterolemia
Dlouha D., Blaha M., Rohlova E. et al.
Cell Research, 2021Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects
Yu S., Di C., Chen S. et al.
Journal of Obesity, 2021Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort
Korduner J., Nilsson P., Melander O. et al.
Nephrology Dialysis Transplantation, 2021Novel biomarkers of inflammation, kidney function and chronic kidney disease in the general population
Nano J., Schöttker B., Lin J. et al.
Molecular & Cellular Proteomics, 2021Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
Krishnan S., Nordqvist H., Ambikan A. et al.
Scientific Reports, 2021Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure
Laudanski K., Okeke T., Hajj J. et al.
Journal of Neuroinflammation, 2021Differential chemokine alteration in the variants of primary progressive aphasia—a role for neuroinflammation
Sogorb-Esteve A., Swift I., Woollacott I. et al.
Food & Nutrition Research, 2021Evaluation of Colocasia esculenta Schott in anti-cancerous properties with proximity extension assays
Wu L., Wang Y., Wang X. et al.
British Journal of Anaesthesia, 2021Vasopressin infusion in COVID-19 critical illness is not associated with impaired viral clearance: a pilot study
Leisman, D. E., Mehta et al.
Molecular & Cellular Proteomics, 2021Assessing the Preanalytical Variability of Plasma and Cerebrospinal Fluid Processing and Its Effects on Inflammation-Related Protein Biomarkers
Huang J., Khademi M., Lindhe ?. et al.
Clinical Proteomics, 2021Association between cardiovascular disease- and inflammation-related serum biomarkers and poor lung function in elderly
Egervall K., Rosso A., Elmståhl S.
Blood Advances, 2021PD-1 inhibition in advanced myeloproliferative neoplasms
Hobbs G., Cimen Bozkus C., Moshier E. et al.
Molecular & Cellular Proteomics, 2021Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification
Ren A., Diamandis E., Kulasingam V.
Journal of Neurochemistry, 2021Antimicrobial protein REG3A and signaling networks are predictive of stroke outcomes
Sands M., Frank J., Maglinger B. et al.
Atherosclerosis, 2021Carotid atherosclerosis, changes in tissue remodeling and repair in patients with aortic coarctation
Hlebowicz J., Holm J., Lindstedt S. et al.
Med, 2021Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case series
van Laarhoven A., Kurver L., Overheul G. et al.
Olink Explore 3072/384
Frontiers in Immunology, 2021Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals
Tserel L., Jõgi P., Naaber P. et al.
3195 publications
Items per page
2461-2480 of 3195 publications